Lineage Cell Therapeutics
Price & Volume
Stats
See moreOpen | $1.08 |
Previous Close | $1.08 |
Day Range | $1.06-$1.10 |
52W Range | $1-$2.09 |
Market Cap | $273.1M |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $13M |
Revenue Growth (YoY) | -61.3% |
Gross Profit (12 Mos) | -$7.5M |
Diluted EPS | -$0.19 |
News
See moreYahoo Finance • 15 days ago
Lineage Cell Therapeutics Q2 Earnings Call Highlights
Yahoo Finance • 18 days ago
Lineage outlines cash runway into Q3 2028 while targeting COR1 in vivo data by year-end
Yahoo Finance • 3 months ago
Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors.
Yahoo Finance • 3 months ago
Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 72 |